An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis C

NCT04301882 · clinicaltrials.gov ↗

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: interferon combined with ribavirin (PR) antiviral therapy
DRUG: direct antiviral drugs (DAAs)

Sponsor

Beijing Ditan Hospital